Hong Kong sticking with 10-valent pneumococcal vaccine for now
This article was originally published in Scrip
Hong Kong's health authorities have said that they have no plans at present to stop using a 10-valent pneumococcal conjugate vaccine in the territory's paediatric immunisation programme, despite the emergence elsewhere in Asia of serotypes that it does not protect against.
You may also be interested in...
Given its ever-growing role as a critical component of the global biopharma industry, you can’t afford not to be up to speed on Asia. This biweekly selection of insights from our experienced on-the-ground team will help.
Plus deals involving LegoChem/Pyxix, Biohaven/Sosei Heptares, Kyowa Kirin/Helsinn, Dr. Reddy’s/Glenmark, Eisai/Wren, KoBioLabs/Kolmar Korea, Y-Biologics/Pierre Fabre, Generex/Chinese consortium.
Join us for a brief audio tour around the past week's major global biopharma industry developments, in this podcast version of Scrip's Five Must-Know Things.